Voltar
Artigo Revisado por pares
BIBTEX RIS

A phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl cyclase C

2017; Springer Science+Business Media; Volume: 35; Issue: 5 Linguagem: Inglês

10.1007/s10637-017-0473-9

ISSN

1573-0646

Autores

Khaldoun Almhanna, David Wright, T. Macarulla Mercadé, Jean‐Luc Van Laethem, Antonio Cubillo Gracián, Carmen Guillén‐Ponce, Jason E. Faris, Carolina Muriel López, Richard Hubner, Johanna C. Bendell, Alain Bols, Jaime Feliú, Naureen Starling, Peter C. Enzinger, Devalingham Mahalingham, Wells A. Messersmith, Huyuan Yang, Adedigbo A. Fasanmade, Hadi Danaee, Thea Kalebic,

Tópico(s)

Cancer Cells and Metastasis

Referência(s)